Timothy Bradshaw, Ph.D., is an accomplished professional in drug development with extensive experience across various leadership roles in the biopharmaceutical industry. As the Executive Director of Drug Development Solutions at ICON plc since September 2017, Bradshaw provides consulting support for clients in advancing a range of therapeutic assets. Previously, as Chief Clinical Officer at Entera Health, Inc., Bradshaw contributed to the company’s foundational strategies and led the clinical approach for EnteraGam. Additional leadership roles include President and CEO of NeuroNano Pharma, Executive Vice President at Tenax Therapeutics, and various project management positions at PPD, Talecris Biotherapeutics, and GlaxoSmithKline. Bradshaw's educational background includes a PhD in Biochemistry from the University of South Carolina and a Post-Doctoral Fellowship in Molecular Toxicology from the Medical University of South Carolina.
This person is not in any teams
This person is not in any offices